TMPRSS2 and prostate cancer: Taken together, fusion-typing of a novel panel of TMPRSS2:ETS fusion markers allows detection of diverse fusion types in urine; multiple alternative fusion markers other than the common subtype I provide improved detection of prostate cancer in prebiopsy patients.